There are 2789 resources available
1422P - Identification and validation of novel microenvironment-based immune molecular subgroups of esophageal squamous-cell carcinoma
Presenter: Yifan Zhang
Session: ePoster Display
1423P - Genomic landscape in advanced gastric cancer from real-world data (RWD) of clinical genomic testing
Presenter: Hiroyuki Yamamoto
Session: ePoster Display
1424P - Landscape of germline mutations in Chinese patients with gastric cancer
Presenter: Yujian Zeng
Session: ePoster Display
1425P - Immune microenvironment and genomic alterations interpret heterogeneous response to immunotherapy in EBV-associated gastric carcinoma
Presenter: Zhi Peng
Session: ePoster Display
1426P - The utility of the prognostic index for practicing the continuum of care in advanced gastric cancer: The suitability assessment and modification of the JCOG prognostic index in real-world data
Presenter: Keitaro Shimozaki
Session: ePoster Display
1427P - Cancer/testis antigen expression landscape in gastroesophageal adenocarcinoma
Presenter: Sarbajit Mukherjee
Session: ePoster Display
1428P - Circulating nutritional biomarkers and their association with survival in patients with metastatic gastroesophageal cancer
Presenter: Hannah Christina Puhr
Session: ePoster Display
1429P - Pathological regression in patients with microsatellite instability (MSI) receiving perioperative atezolizumab in combination with FLOT vs. FLOT alone for resectable esophagogastric adenocarcinoma: Results from the DANTE trial of the German Gastric Group at the AIO and SAKK
Presenter: Salah-Eddin Al-Batran
Session: ePoster Display
1430P - Frequency of PD-L1 positivity and microsatellite instability (MSI) in the DANTE trial: Perioperative atezolizumab with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma. A randomized, open-label phase IIb trial of the German gastric group at the AIO and SAKK
Presenter: Christina Kopp
Session: ePoster Display
1431P - Descriptive analysis and prognostic factors of microsatellite instability (MSI) gastric cancer patients (pts) compared to microsatellite stable (MSS) pts in a tertiary hospital
Presenter: Oriol Mirallas
Session: ePoster Display